Oxicams: metabolic disposition in man and animals.
Woolf
T F
TF
Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.
Radulovic
L L
LL
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism / Q000493:pharmacokinetics*; D004285:Dogs; D005260:Female; D000882:Haplorhini; D006801:Humans; D008297:Male; D010894:Piroxicam / Q000031:analogs & derivatives / Q000378:metabolism / Q000493:pharmacokinetics; D051381:Rats; D013843:Thiazines / Q000378:metabolism / Q000493:pharmacokinetics*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D013843:Thiazines; D010894:Piroxicam; C013580:isoxicam; C100301:sudoxicam; C032801:tenoxicam